Back
Defiance Nasdaq 100 Income Target ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Sell
32
QQQT
Defiance Nasdaq 100 Income Target ETF
Last Price:
$17.35
Seasonality Move:
-13.24%
Buy
64
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$88.46
Seasonality Move:
-32.16%
Sell
32
Defiance Nasdaq 100 Income Target ETF (QQQT)
is a Sell
Is Defiance Nasdaq 100 Income Target ETF a Buy, Sell or Hold?
-
The current Defiance Nasdaq 100 Income Target ETF [QQQT] share price is $17.68. The Score for QQQT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
QQQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $88.08. The Score for DRUG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QQQT Stock Price Chart
What is Defiance Nasdaq 100 Income Target ETF's stock price today?
-
The Defiance Nasdaq 100 Income Target ETF share price today is $17.68Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QQQT is experiencing selling pressure, which indicates risk of future bearish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $88.08Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.
QQQT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 38.9 | Sell |
| Chaikin Money Flow: | 15288 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.77 | Buy |
| Relative Strength Index (14 RSI): | 66.44 | Buy |
| Chaikin Money Flow: | -23974 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.51 - 82.89) | Buy |
| Bollinger Bands (100): | (41.26 - 68.88) | Buy |
QQQT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.93 | Sell |
| 20-day SMA: | 17.9 | Sell |
| 50-day SMA: | 18.19 | Sell |
| 200-day SMA: | 17.64 | Buy |
| 8-day EMA: | 17.86 | Sell |
| 20-day EMA: | 17.97 | Sell |
| 50-day EMA: | 18.09 | Sell |
| 200-day EMA: | 18.13 | Sell |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.48 | Buy |
| 20-day SMA: | 74.4 | Buy |
| 50-day SMA: | 65.57 | Buy |
| 200-day SMA: | 42.82 | Buy |
| 8-day EMA: | 85.2 | Buy |
| 20-day EMA: | 77.09 | Buy |
| 50-day EMA: | 66.93 | Buy |
| 200-day EMA: | 47.3 | Buy |
Defiance Nasdaq 100 Income Target ETF Earnings Growth & QQQT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
Defiance Nasdaq 100 Income Target ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||